50 SMA Rising- Positional TradeDisclaimer: I am not a Sebi registered adviser.
This Idea is publish purely for educational purpose only before investing in any stocks please take advise from your financial adviser.
Its 50 SMA Rising Strategy. Suitable for Positional Trading Initial Stop loss lowest of last 2 candles and keep tra
2.03 INR
46.84 M INR
3.95 B INR
About AAREY DRUGS & PHARM LTD
Sector
Industry
CEO
Mihir Rajesh Ghatalia
Website
Headquarters
Mumbai
Founded
1990
ISIN
INE198H01019
FIGI
BBG000D2FHM2
Aarey Drugs & Pharmaceuticals Ltd. engages in the trade and manufacture of pharmaceutical ingredients, drug intermediates, specialty chemicals, industrial solvents, and chemicals. Its products include mono methyl urea, dimethyl urea, theobromine, theophylline, mefanamic acid, bromomethyl, and dioxolane. The company was founded by Rajesh Pranlal Ghatalia on May 15, 1990 and is headquartered in Mumbai, India.
52 Week High Breakout - Swing TradeDisclaimer: I am Not SEBI Registered adviser, please take advise from your financial adviser before investing in any stocks. Idea here shared is for education purpose only.
Stock has given break out. Buy above high. Keep this stock in watch list.
Buy above the High and do not forget to keep stop lo
Aarey Drugs & Pharmaceuticals Ltd
Target given in the chart
SL - as per your risk apetitie
Market Cap
₹ 161 Cr.
Current Price
₹ 63.5
High / Low
₹ 68.0 / 37.0
Stock P/E
24.7
Book Value
₹ 52.3
Dividend Yield
0.00 %
ROCE
4.44 %
ROE
3.78 %
Face Value
₹ 10.0
Price to book value
1.21
Intrinsic Value
₹ 32.8
PEG Ratio
-3.82
Resistance BreakoutPlease look into the chart for a detailed understanding.
Consider these for short-term & swing trades with 2% profit.
For BTST trades consider booking
target for 1% - 2%
For long-term trades look out for resistance drawn above closing.
Please consider these ideas for educational purpose
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of AAREYDRUGS is 58.68 INR — it has decreased by −1.31% in the past 24 hours. Watch AAREY DRUGS & PHARMACEUTICALS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange AAREY DRUGS & PHARMACEUTICALS stocks are traded under the ticker AAREYDRUGS.
AAREYDRUGS stock has risen by 8.21% compared to the previous week, the month change is a 45.93% rise, over the last year AAREY DRUGS & PHARMACEUTICALS has showed a 26.06% increase.
AAREYDRUGS reached its all-time high on Sep 5, 2024 with the price of 75.75 INR, and its all-time low was 31.30 INR and was reached on Mar 18, 2025. View more price dynamics on AAREYDRUGS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AAREYDRUGS stock is 6.04% volatile and has beta coefficient of 1.03. Track AAREY DRUGS & PHARMACEUTICALS stock price on the chart and check out the list of the most volatile stocks — is AAREY DRUGS & PHARMACEUTICALS there?
Today AAREY DRUGS & PHARMACEUTICALS has the market capitalization of 1.65 B, it has increased by 11.65% over the last week.
Yes, you can track AAREY DRUGS & PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
AAREYDRUGS net income for the last quarter is 7.18 M INR, while the quarter before that showed 15.96 M INR of net income which accounts for −55.03% change. Track more AAREY DRUGS & PHARMACEUTICALS financial stats to get the full picture.
AAREY DRUGS & PHARMACEUTICALS dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AAREY DRUGS & PHARMACEUTICALS EBITDA is 56.65 M INR, and current EBITDA margin is 2.41%. See more stats in AAREY DRUGS & PHARMACEUTICALS financial statements.
Like other stocks, AAREYDRUGS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AAREY DRUGS & PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AAREY DRUGS & PHARMACEUTICALS technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AAREY DRUGS & PHARMACEUTICALS stock shows the strong buy signal. See more of AAREY DRUGS & PHARMACEUTICALS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.